Molecular Partners AG is a clinical-stage biopharmaceutical company that develops and commercializes therapeutic proteins for various diseases. Its product candidates are in various stages of clinical trials, including Abicipar for age-related macular degeneration, MP0310 for immuno-oncology, and MP0533 for acute myeloid leukemia. The company has collaborations with Novartis, Amgen, Allergan, and AbbVie, among others, and is headquartered in Schlieren, Switzerland.